Word: marketing
(lookup in dictionary)
(lookup stats)
Dates: during 1950-1959
Sort By: most recent first
(reverse)
Though a firm can get its foot in the common market simply by licensing a European firm to manufacture a U.S. product, most U.S. companies, especially those already established in market countries, prefer to set up new branches or subsidiaries instead. They have found it best to buy existing plants, since building a new plant in Europe often means building housing for workers as well...
Many U.S. firms have discovered that the best and safest method is to buy a partnership in a European firm. Faced with much stiffer competition in the common market, European manufacturers are eager to get U.S. cash and technical know-how to help them meet it. A U.S. firm, on the other hand, can profit from its European partner's intimate knowledge of his market and area...
Economists hope that the common market will later be joined by a proposed European free-trade area, consisting of the United Kingdom and five other countries outside the common market, to form a community of more than 240 million potential customers. Many U.S. firms are holding back to see if this will happen; they would prefer to get into England under lower tariffs, thus gain access to the Commonwealth trading area as well as the common market. But foreign traders contend that now is the best time for U.S. firms to enter the market area. Says Lawyer Ball: "There...
Rothmans was so bluntly frank because it is trying to plug its own filter brand (called Rothmans) at the expense of the industry. The company is struggling to win a major market in Canada, and Supersalesman O'Neil-Dunne, speaking in Toronto, claimed that Rothmans' king-size filter brand yielded 14.4% to 38.7% less tars than the four other bestselling Canadian filters. Furthermore, "an increasing section of scientific opinion believes that if the tar intake from a single cigarette were reduced to 18 milligrams,† there would be a significant reduction in the risk of lung cancer...
Cent per Dose. In addition, FTC singled out Pfizer for a more serious charge, saying that it had "made false, misleading and incorrect" statements when it obtained the basic tetracycline patent in 1955. Tetracycline already had been on the market for a year from various mak ers, and the patented method of manufacture was not truly an invention because it was "obvious to anyone having ordinary skill" in the antibiotics art. If sustained by the Federal Trade Commission after hearings start Oct. 1, this charge could lead to an FTC request to relax the Pfizer patent...